Literature DB >> 26034998

Functionalized Collagen Scaffold Neutralizing the Myelin-Inhibitory Molecules Promoted Neurites Outgrowth in Vitro and Facilitated Spinal Cord Regeneration in Vivo.

Xing Li1,2, Jin Han1, Yannan Zhao1, Wenyong Ding3, Jianshu Wei1, Sufang Han1, Xianping Shang3, Bin Wang1, Bing Chen1, Zhifeng Xiao1, Jianwu Dai1.   

Abstract

Research has demonstrated that many myelin-associated inhibitory molecules jointly contribute to the failure of adult spinal cord regeneration. Therapies comprehensively targeting the multiple inhibitory nature of the injured spinal cord are being concerned. Here, two collagen-binding proteins, CBD-EphA4LBD and CBD-PlexinB1LBD, were constructed, respectively, to neutralize the axon guidance molecules ephrinB3 and sema4D that inhibit the regeneration of nerve fibers. The two neutralizing proteins have proven their ability to specifically bind collagen and to continuously release from collagen scaffolds. They could also promote neurites outgrowth of cerebellar granular neurons and dorsal root ganglion neurons in vitro. Subsequently, the functionalized collagen scaffolds by physically absorbing NEP1-40 and immobilizing CBD-EphA4LBD and CBD-PlexinB1LBD were transplanted into a rat T10 complete spinal cord transection model. Our results showed that rats that received the treatment of transplanting the functionalized collagen scaffold exhibited great advantage on axonal regeneration and locomotion recovery after spinal cord injury.

Entities:  

Keywords:  collagen binding domain; functionalized collagen scaffold; myelin-inhibitory molecules; neutralizing protein; spinal cord injury

Mesh:

Substances:

Year:  2015        PMID: 26034998     DOI: 10.1021/acsami.5b03879

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  8 in total

Review 1.  Progress and perspectives of neural tissue engineering.

Authors:  Xiaosong Gu
Journal:  Front Med       Date:  2015-12       Impact factor: 4.592

2.  Clinical Study of NeuroRegen Scaffold Combined With Human Mesenchymal Stem Cells for the Repair of Chronic Complete Spinal Cord Injury.

Authors:  Yannan Zhao; Fengwu Tang; Zhifeng Xiao; Guang Han; Nuo Wang; Na Yin; Bing Chen; Xianfeng Jiang; Chen Yun; Wanjun Han; Changyu Zhao; Shixiang Cheng; Sai Zhang; Jianwu Dai
Journal:  Cell Transplant       Date:  2017-02-09       Impact factor: 4.064

Review 3.  Application of Collagen-Based Scaffolds for the Treatment of Spinal Cord Injuries in Animal Models: A Literature Update.

Authors:  Dimitrios Zachariou; Dimitrios Stergios Evangelopoulos; Meletis Rozis; Eftychios Papagrigorakis; Athanasios Galanis; Michail Vavourakis; Spyros G Pneumaticos; John Vlamis
Journal:  Cureus       Date:  2022-06-16

4.  Future biomaterials for enhanced cell-substrate communication in spinal cord injury intervention.

Authors:  Pradeep Kumar
Journal:  Future Sci OA       Date:  2017-11-15

5.  Significant Improvement of Acute Complete Spinal Cord Injury Patients Diagnosed by a Combined Criteria Implanted with NeuroRegen Scaffolds and Mesenchymal Stem Cells.

Authors:  Zhifeng Xiao; Fengwu Tang; Yannan Zhao; Guang Han; Na Yin; Xing Li; Bing Chen; Sufang Han; Xianfeng Jiang; Chen Yun; Changyu Zhao; Shixiang Cheng; Sai Zhang; Jianwu Dai
Journal:  Cell Transplant       Date:  2018-06-05       Impact factor: 4.064

Review 6.  Recent Advances in Cell and Functional Biomaterial Treatment for Spinal Cord Injury.

Authors:  Tianyi Liu; Wenhao Zhu; Xiaoyu Zhang; Chuan He; Xiaolong Liu; Qiang Xin; Kexin Chen; Haifeng Wang
Journal:  Biomed Res Int       Date:  2022-08-08       Impact factor: 3.246

Review 7.  Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia.

Authors:  Fengxuan Han; Jiayuan Wang; Luguang Ding; Yuanbin Hu; Wenquan Li; Zhangqin Yuan; Qianping Guo; Caihong Zhu; Li Yu; Huan Wang; Zhongliang Zhao; Luanluan Jia; Jiaying Li; Yingkang Yu; Weidong Zhang; Genglei Chu; Song Chen; Bin Li
Journal:  Front Bioeng Biotechnol       Date:  2020-03-24

8.  NeuroRegen Scaffolds Combined with Autologous Bone Marrow Mononuclear Cells for the Repair of Acute Complete Spinal Cord Injury: A 3-Year Clinical Study.

Authors:  Wugui Chen; Ying Zhang; Sizhen Yang; Jing Sun; Hao Qiu; Xu Hu; Xiaojian Niu; Zhifeng Xiao; Yannan Zhao; Yue Zhou; Jianwu Dai; Tongwei Chu
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.